Annexon ANNX
NASDAQ ANNX
$4.87 +0.03 (+0.62%)
As of: Sep 4, 2026 · 3:59 PM EDT

Annexon (ANNX) Total Current Liabilities (2019 - 2026)

Annexon (ANNX) posted quarterly Total Current Liabilities of $35.9 million for Q1 2026, up 7.12% year-over-year from $33.5 million in Q1 2025, and down 15.7% quarter-over-quarter from $42.6 million in Q4 2025.

Analysis

Annexon (ANNX) Total Current Liabilities (2019 - 2026) Analysis & Trends

Annexon's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $35.9 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 7.12% year-over-year to $35.9 million; the TTM figure through Mar 2026 stood at $35.9 million (up 7.12% YoY), while the FY2025 annual figure was $42.6 million, up 39.72% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $35.9 million, down from $42.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $43.6 million in Q3 2025, with the low at $13.1 million in Q1 2024.
  • The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $25.5 million.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 42.75% in 2024, then soared 155.44% in 2025.
  • Annexon's Total Current Liabilities stood at $22.4 million in 2022, then fell by 19.82% to $17.9 million in 2023, then jumped by 70.19% to $30.5 million in 2024, then surged by 39.72% to $42.6 million in 2025, then dropped by 15.7% to $35.9 million in 2026.
  • Business Quant data shows ANNX's Total Current Liabilities at $35.9 million in Q1 2026, $42.6 million in Q4 2025, and $43.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Annexon 982.93 Mn 982.93 Mn - 38.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.48 Mn
Mar 31, 2026 35.94 Mn
Dec 31, 2025 42.63 Mn
Sep 30, 2025 43.58 Mn
Jun 30, 2025 40.64 Mn
Mar 31, 2025 33.55 Mn
Dec 31, 2024 30.51 Mn
Sep 30, 2024 20.05 Mn
Jun 30, 2024 17.15 Mn
Mar 31, 2024 13.13 Mn
Dec 31, 2023 17.93 Mn
Sep 30, 2023 17.17 Mn
Jun 30, 2023 17.89 Mn
Mar 31, 2023 22.94 Mn
Dec 31, 2022 22.36 Mn
Sep 30, 2022 20.22 Mn
Jun 30, 2022 20.25 Mn
Mar 31, 2022 17.05 Mn
Dec 31, 2021 21.74 Mn
Sep 30, 2021 11.92 Mn